Michele Uematsu
Nurse Practitioner · Honolulu, HINPI 1811748239
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,380 of the $3,854 with a category attached, or 87.7%. It is spread thinly across 40 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,082, more than ten times the $16 reported in 2022. Among nurse practitioner clinicians in HI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 131 payments — averaging $29.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Caris MPI, Inc.$626
- AbbVie$299
- AstraZeneca$295
- Pfizer$252
- Astellas Pharma US Inc$235
- Daiichi Sankyo Inc.$192
- plus $2K from 34 others
What the payments were for
- Consulting fees$37510%
- Food & beverage$3,38088%
- Education$993%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Caris MPI, Inc. | 6 | $626 |
| AbbVie | 14 | $299 |
| AstraZeneca(2 entities) | 12 | $295 |
| Pfizer | 11 | $252 |
| Astellas Pharma US Inc | 6 | $235 |
| Daiichi Sankyo Inc. | 7 | $192 |
| Novartis | 8 | $165 |
| Biomarin Pharmaceutical Inc. | 1 | $120 |
| Johnson & Johnson | 4 | $119 |
| Azurity Pharmaceuticals, Inc. | 5 | $107 |
| Seagen Inc. | 1 | $99 |
| Incyte Corporation | 4 | $94 |
| Exelixis Inc. | 4 | $91 |
| Merck | 4 | $84 |
| Tersera Therapeutics LLC | 2 | $75 |
| Pharmacosmos Therapeutics Inc. | 3 | $74 |
| Sanofi | 3 | $70 |
| Lilly USA, LLC | 3 | $70 |
| Spectrum Pharmaceuticals Inc. | 2 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $61 |
| Recordati_rare_diseases_inc. | 2 | $54 |
| Syndax Pharmaceuticals, Inc. | 2 | $52 |
| E.r. Squibb & Sons, L.L.C. | 3 | $50 |
| Eisai Inc. | 2 | $48 |
| Rigel Pharmaceuticals, Inc. | 2 | $46 |
| Aadi Bioscience, Inc. | 2 | $46 |
| Genentech, Inc. | 2 | $44 |
| Sobi, Inc | 2 | $43 |
| Springworks Therapeutics, Inc. | 1 | $37 |
| Novo Nordisk | 1 | $31 |
| Kyowa Kirin, Inc. | 1 | $26 |
| Coherus Oncology, Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Bayer | 1 | $25 |
| ADC Therapeutics America, Inc. | 1 | $24 |
| Gilead | 1 | $20 |
| Agios Pharmaceuticals, Inc. | 1 | $19 |
| Taiho Oncology, Inc. | 1 | $17 |
| Stemline Therapeutics Inc. | 1 | $17 |
| Janssen Scientific Affairs, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MI CANCER SEEK$531
- XTANDI$140
- Roctavian$120
How this compares
$3,854 in reported general payments places this provider in the 90th percentile of 215 nurse practitioner providers in Hawaii.
Other nurse practitioner in Honolulu
- Ashley SpringerHonolulu$43K
- Sung JungHonolulu$29K
- Judy KoHonolulu$17K
- Bryce MontalboHonolulu$15K
- Rita AbreuHonolulu$9K
- Jinny ChingHonolulu$7K
- Nancy BanhHonolulu$6K
- Kelly FuruikeHonolulu$6K
- Qi ZhiHonolulu$5K
- Mio OsakiHonolulu$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.